Skip to main content
. 2017 May 19;7:100. doi: 10.3389/fonc.2017.00100

Figure 3.

Figure 3

Binding affinity and specificity for EGFRvIII antigen and on cells. (A,B) Concentration-dependent binding of different His-tagged antibody fragments (A) or monoclonal antibodies (B) to recombinant EGFRvIII-Fc, EGFRvIIItrunc-Fc, or EGFR-Fc coated in ELISA. KD values indicated in the graphs were calculated with the equation one site binding (hyperbola), least squares (ordinary) fit using GraphPad Prism. (C–E) Concentration-dependent cell binding of different antibody constructs analyzed by sigmoidal dose–response/four parameter logistic fit: (C) CHO cells stably transfected to overexpress EGFRvIII, (D) DK-MG cells expressing EGFRvIII and EGFR, (E) A431 cells overexpressing EGFR (cetuximab staining signals on A431 cells due to high intensity are plotted on the separate left axis, signals of all other antibodies are plotted on the right axis with different scale). (F) FACS histogram overlay of A431 cells stained with saturating concentrations of ch806 or cetuximab or detection antibodies alone. MFI, mean fluorescence intensity, ctrl., control antibody staining at single dose of 10 µg/mL.